In 'skinny' label fight between Teva and GSK, Supreme Court asks Biden admin for help

After Israeli-American copycat drug giant Teva this summer petitioned the U.S. Supreme Court to overturn its $235 million loss in the long-running patent kerfuffle, the High Court has asked the Biden administration for its opinion on whether to reconsider the verdict, Reuters first reported.